Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
40
OLYMY Quote, Financials, Valuation and Earnings
Last price:
$12.64
Seasonality move
:
2.49%
Day range:
$12.44 - $12.99
52-week range:
$11.09 - $15.90
Dividend yield:
0%
P/E ratio:
22.07x
P/S ratio:
2.19x
P/B ratio:
2.82x
Volume:
26.1K
Avg. volume:
43.1K
1-year change:
-13.81%
Market cap:
$14B
Revenue:
$6.5B
EPS (TTM):
$0.58
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Olympus Corp. has -- downside to fair value with a price target of -- per share.
OLYMY vs. S&P 500
-
Over the past 5 trading days, Olympus Corp. has underperformed the S&P 500 by -2.22% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Olympus Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Olympus Corp. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Olympus Corp. reported revenues of $1.7B.
Earnings Growth
-
Olympus Corp. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Olympus Corp. reported earnings per share of $0.12.
Enterprise value:
14.4B
EV / Invested capital:
2.21x
Price / LTM sales:
2.19x
EV / EBIT:
13.81x
EV / Revenue:
2.21x
PEG ratio (5yr expected):
0.64x
EV / Free cash flow:
61.05x
Price / Operating cash flow:
60.63x
Enterprise value / EBITDA:
9.69x
Gross Profit (TTM):
$4.4B
Return On Assets:
6.84%
Net Income Margin (TTM):
9.92%
Return On Equity:
13.16%
Return On Invested Capital:
9.74%
Operating Margin:
16.7%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $6.5B | $6.4B | $6.5B | $1.6B | $1.7B | |
| Gross Profit | $4.4B | $4.4B | $4.4B | $1.1B | $1.1B | |
| Operating Income | $1.2B | $1.1B | $1B | $319.5M | $280.7M | |
| EBITDA | $1.6B | $1.6B | $1.5B | $426.8M | $394.2M | |
| Diluted EPS | $1.70 | $0.43 | $0.58 | $0.20 | $0.12 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5B | $5.5B | $6.2B | $4.6B | $4.1B | |
| Total Assets | $10.6B | $10.3B | $10.8B | $9.6B | $9.4B | |
| Current Liabilities | $2.6B | $2.5B | $2.8B | $2.9B | $2B | |
| Total Liabilities | $6.6B | $5.8B | $5.3B | $4.6B | $4.4B | |
| Total Equity | $4B | $4.4B | $5.5B | $4.9B | $5B | |
| Total Debt | $3B | $2.4B | $1.7B | $912.7M | $1.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $600.1M | $978.7M | $788M | $453.9M | $250.4M | |
| Cash From Investing | $2.6B | -$636.3M | -$582.1M | -$96M | -$225.9M | |
| Cash From Financing | -$1.7B | -$2B | -$910.4M | -$511.6M | -$690.8M | |
| Free Cash Flow | $98.4M | $540.6M | $236.7M | $340.8M | $53.6M | |
OLYMY
Sector
Market Cap
$14B
$27.9M
Price % of 52-Week High
79.91%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
4.55%
-1.49%
1-Year Price Total Return
-13.81%
-16.66%
Beta (5-Year)
0.703
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
-21.36%
Growth streak:
2 years
Technicals
8-day SMA
Sell
Level
$12.90
200-day SMA
Buy
Level
$12.59
Bollinger Bands (100)
Buy
Level
11.99 - 13.05
Chaikin Money Flow
Buy
Level
20.6M
20-day SMA
Sell
Level
$13.10
Relative Strength Index (RSI14)
Sell
Level
44.40
ADX Line
Sell
Level
10.03
Williams %R
Neutral
Level
-76.087
50-day SMA
Sell
Level
$12.81
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
14.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.6621)
Buy
CA Score
(Annual)
Level (0.3929)
Buy
Beneish M-Score
(Annual)
Level (-2.6232)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.7581)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Endoscope Business and Therapeutic Equipment Business. The Endoscope Business segment develops and sells medical endoscopes and imaging systems for minimally invasive diagnostics. The Therapeutic Equipment Business segment provides medical devices and systems used in surgical and therapeutic procedures across various specialties. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.
Stock Forecast FAQ
In the current month, OLYMY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OLYMY average analyst price target in the past 3 months is --.
-
Where Will Olympus Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Olympus Corp. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Olympus Corp.?
Analysts are divided on their view about Olympus Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Olympus Corp. is a Sell and believe this share price will rise from its current level to --.
-
What Is Olympus Corp.'s Price Target?
The price target for Olympus Corp. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is OLYMY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Olympus Corp. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of OLYMY?
You can purchase shares of Olympus Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Olympus Corp. shares.
-
What Is The Olympus Corp. Share Price Today?
Olympus Corp. was last trading at $12.64 per share. This represents the most recent stock quote for Olympus Corp.. Yesterday, Olympus Corp. closed at $12.71 per share.
-
How To Buy Olympus Corp. Stock Online?
In order to purchase Olympus Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get OLYMY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OLYMY
Sector
P/E ratio
22.07x
23.85x
PEG ratio
0.64x
-0.01x
P/B ratio
2.82x
1.81x
Price / LTM sales
2.19x
1.58x
Growth Metrics
OLYMY
Sector
Revenue growth
4.85%
4.62%
Earnings growth
-38.65%
10.7%
Revenue (5-year growth)
-1.19%
6.5%
Earnings forecast
--
-$0.21
Profitability
OLYMY
Sector
Profitability FY 2024
$4.3B
$3.6M
Return on invested capital
9.74%
-31.87%
Return on assets
6.84%
-28.18%
Return on equity
13.16%
-37.63%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
Feb
13
Estimated Next Earnings Date
Feb
6
Balance Sheet
OLYMY
Sector
Total cash
$1.1B
$26.4M
Short term investments
$15.4M
$25.7M
Total assets
$9.6B
$76.9M
Long term debt
$1.6B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 22
Lamb Weston Holdings, Inc. [LW] is down 2.59% over the past day.
Buy
54
BMRN alert for Dec 22
BioMarin Pharmaceutical, Inc. [BMRN] is down 3.03% over the past day.
Buy
82
RKLB alert for Dec 22
Rocket Lab Corp. [RKLB] is up 9.97% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
